

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 5.07473992 |
| 2 | neuronal action potential propagation (GO:0019227) | 5.02000697 |
| 3 | protein localization to endosome (GO:0036010) | 4.93735253 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 4.89790371 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 4.89790371 |
| 6 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.87488793 |
| 7 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.87488793 |
| 8 | detection of temperature stimulus (GO:0016048) | 4.60910588 |
| 9 | cell migration in hindbrain (GO:0021535) | 4.47492228 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.23375561 |
| 11 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.18160916 |
| 12 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.13765760 |
| 13 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.12062403 |
| 14 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.09269113 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.08390372 |
| 16 | negative regulation of microtubule polymerization (GO:0031115) | 4.05343594 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 3.99946726 |
| 18 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.91659623 |
| 19 | protein retention in ER lumen (GO:0006621) | 3.90363357 |
| 20 | barbed-end actin filament capping (GO:0051016) | 3.85594390 |
| 21 | adherens junction assembly (GO:0034333) | 3.81280689 |
| 22 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.78079490 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77264604 |
| 24 | negative regulation of heart rate (GO:0010459) | 3.76993453 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.76560018 |
| 26 | negative regulation of cell size (GO:0045792) | 3.75002073 |
| 27 | cell-substrate junction assembly (GO:0007044) | 3.73602966 |
| 28 | hemidesmosome assembly (GO:0031581) | 3.73159704 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.71193153 |
| 30 | glutamate secretion (GO:0014047) | 3.71018812 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.66541033 |
| 32 | focal adhesion assembly (GO:0048041) | 3.65786373 |
| 33 | cell-substrate adherens junction assembly (GO:0007045) | 3.65786373 |
| 34 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.64228861 |
| 35 | proline transport (GO:0015824) | 3.61471391 |
| 36 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.56818954 |
| 37 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.46836014 |
| 38 | neuronal action potential (GO:0019228) | 3.46682953 |
| 39 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.44660406 |
| 40 | membrane depolarization during action potential (GO:0086010) | 3.41906824 |
| 41 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.41168676 |
| 42 | axon cargo transport (GO:0008088) | 3.38395406 |
| 43 | cellular protein complex localization (GO:0034629) | 3.35757392 |
| 44 | pentose-phosphate shunt (GO:0006098) | 3.35162693 |
| 45 | proline biosynthetic process (GO:0006561) | 3.34329126 |
| 46 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.34084686 |
| 47 | epithelial cell-cell adhesion (GO:0090136) | 3.32554038 |
| 48 | regulation of glucocorticoid secretion (GO:2000849) | 3.30917326 |
| 49 | response to pain (GO:0048265) | 3.29573301 |
| 50 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.28909527 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.28566490 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27297214 |
| 53 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.26949975 |
| 54 | maternal placenta development (GO:0001893) | 3.22714653 |
| 55 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.21636536 |
| 56 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.20947207 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.16566702 |
| 58 | neuromuscular process controlling posture (GO:0050884) | 3.16142902 |
| 59 | hypotonic response (GO:0006971) | 3.15107189 |
| 60 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.13174681 |
| 61 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.13155225 |
| 62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.12153612 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.10076953 |
| 64 | plasma membrane repair (GO:0001778) | 3.09546112 |
| 65 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.07992271 |
| 66 | peripheral nervous system neuron development (GO:0048935) | 3.07441346 |
| 67 | stress fiber assembly (GO:0043149) | 3.07337201 |
| 68 | pinocytosis (GO:0006907) | 3.06030646 |
| 69 | modulation by symbiont of host cellular process (GO:0044068) | 3.05398315 |
| 70 | skin morphogenesis (GO:0043589) | 3.00429625 |
| 71 | negative regulation of cation channel activity (GO:2001258) | 2.99519344 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 2.98494918 |
| 73 | innervation (GO:0060384) | 2.97624580 |
| 74 | sodium ion export (GO:0071436) | 2.97592908 |
| 75 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94937434 |
| 76 | protein complex localization (GO:0031503) | 2.94781733 |
| 77 | establishment of mitochondrion localization (GO:0051654) | 2.94513997 |
| 78 | glucose 6-phosphate metabolic process (GO:0051156) | 2.92792811 |
| 79 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.92765084 |
| 80 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.92611740 |
| 81 | glucose catabolic process (GO:0006007) | 2.91857360 |
| 82 | cell communication by electrical coupling (GO:0010644) | 2.90513417 |
| 83 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.90342328 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 2.90320953 |
| 85 | NADPH regeneration (GO:0006740) | 2.89608878 |
| 86 | protein localization to synapse (GO:0035418) | 2.86533714 |
| 87 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.86257233 |
| 88 | desmosome organization (GO:0002934) | 2.85766302 |
| 89 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.84211417 |
| 90 | neurotransmitter secretion (GO:0007269) | 2.83320069 |
| 91 | positive regulation of nuclease activity (GO:0032075) | 2.82246858 |
| 92 | positive regulation of action potential (GO:0045760) | 2.82041711 |
| 93 | basement membrane organization (GO:0071711) | 2.81971925 |
| 94 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.81796070 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.79423354 |
| 96 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76567558 |
| 97 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.76546447 |
| 98 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.75909428 |
| 99 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.75606902 |
| 100 | activation of Rac GTPase activity (GO:0032863) | 2.75556914 |
| 101 | positive regulation of potassium ion transport (GO:0043268) | 2.75192477 |
| 102 | modulation by virus of host morphology or physiology (GO:0019048) | 2.75089221 |
| 103 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74495799 |
| 104 | regulation of vesicle fusion (GO:0031338) | 2.74463291 |
| 105 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.74388174 |
| 106 | organelle transport along microtubule (GO:0072384) | 2.73995932 |
| 107 | RNA stabilization (GO:0043489) | 2.72091565 |
| 108 | mRNA stabilization (GO:0048255) | 2.72091565 |
| 109 | mating behavior (GO:0007617) | 2.72080835 |
| 110 | locomotory exploration behavior (GO:0035641) | 2.71714928 |
| 111 | modulation by virus of host process (GO:0019054) | 2.71578201 |
| 112 | neuron cell-cell adhesion (GO:0007158) | 2.71191087 |
| 113 | regulation of protein kinase A signaling (GO:0010738) | 2.69316925 |
| 114 | layer formation in cerebral cortex (GO:0021819) | 2.68385247 |
| 115 | response to acidic pH (GO:0010447) | 2.68038894 |
| 116 | enteric nervous system development (GO:0048484) | 2.67598332 |
| 117 | positive regulation of receptor recycling (GO:0001921) | 2.66519957 |
| 118 | activation of MAPKKK activity (GO:0000185) | 2.65791787 |
| 119 | protein targeting to plasma membrane (GO:0072661) | 2.65724525 |
| 120 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.65660300 |
| 121 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.65451971 |
| 122 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.65355934 |
| 123 | cell adhesion mediated by integrin (GO:0033627) | 2.64265124 |
| 124 | endothelial cell chemotaxis (GO:0035767) | 2.63966910 |
| 125 | positive regulation of steroid hormone secretion (GO:2000833) | 2.62879678 |
| 126 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62793368 |
| 127 | endocytic recycling (GO:0032456) | 2.62678118 |
| 128 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.62180127 |
| 129 | tachykinin receptor signaling pathway (GO:0007217) | 2.62056259 |
| 130 | ER-nucleus signaling pathway (GO:0006984) | 2.61918776 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61363960 |
| 132 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.60823491 |
| 133 | regulation of extracellular matrix disassembly (GO:0010715) | 2.59020012 |
| 134 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.58620753 |
| 135 | pyrimidine-containing compound salvage (GO:0008655) | 2.57992519 |
| 136 | pyrimidine nucleoside salvage (GO:0043097) | 2.57992519 |
| 137 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.57984864 |
| 138 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.57984864 |
| 139 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.57736119 |
| 140 | regulation of synapse structural plasticity (GO:0051823) | 2.57718751 |
| 141 | sequestering of actin monomers (GO:0042989) | 2.57656321 |
| 142 | embryonic process involved in female pregnancy (GO:0060136) | 2.57498592 |
| 143 | vesicle transport along microtubule (GO:0047496) | 2.57460591 |
| 144 | response to water (GO:0009415) | 2.56194546 |
| 145 | mannose metabolic process (GO:0006013) | 2.56109413 |
| 146 | regulation of early endosome to late endosome transport (GO:2000641) | 2.55055250 |
| 147 | cellular response to ATP (GO:0071318) | 2.54442973 |
| 148 | chemosensory behavior (GO:0007635) | 2.52750381 |
| 149 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.52367408 |
| 150 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.52367408 |
| 151 | negative regulation of dendrite development (GO:2000171) | 2.52234118 |
| 152 | regulation of nuclease activity (GO:0032069) | 2.51690112 |
| 153 | sensory perception of pain (GO:0019233) | 2.51375084 |
| 154 | retinal ganglion cell axon guidance (GO:0031290) | 2.50966643 |
| 155 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.50178648 |
| 156 | mitochondrion transport along microtubule (GO:0047497) | 2.50178648 |
| 157 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.48973682 |
| 158 | protein maturation by protein folding (GO:0022417) | 2.48793807 |
| 159 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.48673992 |
| 160 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.48002526 |
| 161 | diaphragm development (GO:0060539) | 2.47584902 |
| 162 | exploration behavior (GO:0035640) | 2.47259867 |
| 163 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.47181410 |
| 164 | apoptotic cell clearance (GO:0043277) | 2.46495393 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.46450087 |
| 166 | endodermal cell differentiation (GO:0035987) | 2.46271516 |
| 167 | neuromuscular process controlling balance (GO:0050885) | 2.45524787 |
| 168 | behavioral response to pain (GO:0048266) | 2.45248935 |
| 169 | protein localization to microtubule (GO:0035372) | 2.44034529 |
| 170 | cellular response to unfolded protein (GO:0034620) | 2.42826722 |
| 171 | vocalization behavior (GO:0071625) | 2.42649112 |
| 172 | urea cycle (GO:0000050) | 2.41779306 |
| 173 | regulation of translational fidelity (GO:0006450) | 2.41587758 |
| 174 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41440527 |
| 175 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41412388 |
| 176 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.41380636 |
| 177 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.41380636 |
| 178 | regulation of cell communication by electrical coupling (GO:0010649) | 2.40801495 |
| 179 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.40754478 |
| 180 | synaptic vesicle endocytosis (GO:0048488) | 2.40551021 |
| 181 | positive regulation of axon extension (GO:0045773) | 2.39828147 |
| 182 | cellular response to virus (GO:0098586) | 2.39776506 |
| 183 | actin filament bundle organization (GO:0061572) | 2.39558629 |
| 184 | actin filament bundle assembly (GO:0051017) | 2.39558629 |
| 185 | membrane protein ectodomain proteolysis (GO:0006509) | 2.38767541 |
| 186 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36934178 |
| 187 | response to laminar fluid shear stress (GO:0034616) | 2.36116953 |
| 188 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.35607074 |
| 189 | retrograde transport, endosome to Golgi (GO:0042147) | 2.35557737 |
| 190 | hyaluronan catabolic process (GO:0030214) | 2.35148709 |
| 191 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.34323830 |
| 192 | adenine nucleotide transport (GO:0051503) | 2.33942976 |
| 193 | negative regulation of focal adhesion assembly (GO:0051895) | 2.32786299 |
| 194 | negative regulation of cell junction assembly (GO:1901889) | 2.32786299 |
| 195 | negative regulation of adherens junction organization (GO:1903392) | 2.32786299 |
| 196 | vesicle coating (GO:0006901) | 2.32470554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97068786 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.78377704 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89327631 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81144413 |
| 5 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74706405 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.69143586 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66493553 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66493553 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65389844 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61140531 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58879184 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57000474 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45211293 |
| 14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41512020 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37359703 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.34997297 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.32932818 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.31648676 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.30976064 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25984262 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.22690594 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17867276 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16902234 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13206869 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11196920 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.10063186 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06786438 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03051405 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98916169 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97545487 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97472216 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95472940 |
| 33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89023602 |
| 34 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.87841509 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.87573928 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86564228 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84950641 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84276738 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83585354 |
| 40 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.82991885 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81028201 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77783328 |
| 43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.74951646 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.73910159 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69980416 |
| 46 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.66206461 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65361121 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64380267 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64009741 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63031380 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.62629457 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61573773 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59053398 |
| 54 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.54175101 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.52855370 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52654351 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52100546 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.51971872 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51836333 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49625717 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48184060 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43714758 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43598715 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.43236313 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43206488 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43050091 |
| 67 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42884517 |
| 68 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.41096643 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38700365 |
| 70 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37326798 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37088183 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35616321 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33388007 |
| 74 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.32128874 |
| 75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.29972041 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29755548 |
| 77 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29377486 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28434068 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.28428824 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28120352 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27761115 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26311377 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25768577 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25697872 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25522562 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24311861 |
| 87 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23784114 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23561581 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.23525743 |
| 90 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23513082 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22307512 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22223995 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22072757 |
| 94 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21982125 |
| 95 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21040726 |
| 96 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19988781 |
| 97 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19819275 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19758169 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19555249 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19225102 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19153474 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18257535 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18059922 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18051299 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18010478 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17769503 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16976045 |
| 108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16185908 |
| 109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15868067 |
| 110 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.14565635 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13040345 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11491215 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11111484 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10385894 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08942460 |
| 116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08251256 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07319193 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07116860 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06940955 |
| 120 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06408918 |
| 121 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06302437 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06206624 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05873784 |
| 124 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04778078 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04419620 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04232945 |
| 127 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03048252 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03037089 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02726908 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02608368 |
| 131 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01916924 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01872861 |
| 133 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01261650 |
| 134 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01042012 |
| 135 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00714566 |
| 136 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00355142 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99910333 |
| 138 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99334572 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98368550 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98338552 |
| 141 | MAF_26560356_Chip-Seq_TH2_Human | 0.97670772 |
| 142 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97457517 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97369002 |
| 144 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97059930 |
| 145 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96111964 |
| 146 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95533637 |
| 147 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95028068 |
| 148 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94972509 |
| 149 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94652356 |
| 150 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93919171 |
| 151 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93825102 |
| 152 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93176730 |
| 153 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92165605 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91803985 |
| 155 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91721818 |
| 156 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90731513 |
| 157 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90258865 |
| 158 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90148206 |
| 159 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88004675 |
| 160 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87647594 |
| 161 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86601205 |
| 162 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85027347 |
| 163 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84440191 |
| 164 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83514801 |
| 165 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.82910106 |
| 166 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81876291 |
| 167 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80233352 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80105643 |
| 169 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80023250 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79447206 |
| 171 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.78518802 |
| 172 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77656052 |
| 173 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76399131 |
| 174 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76399131 |
| 175 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.76355686 |
| 176 | AR_19668381_ChIP-Seq_PC3_Human | 0.76289973 |
| 177 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76088134 |
| 178 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.73197876 |
| 179 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73060202 |
| 180 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.72920009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 5.25904203 |
| 2 | MP0002735_abnormal_chemical_nociception | 5.17986477 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.45885561 |
| 4 | MP0004270_analgesia | 4.14094445 |
| 5 | MP0004858_abnormal_nervous_system | 3.93673610 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.55351953 |
| 7 | MP0002734_abnormal_mechanical_nocicepti | 3.43606942 |
| 8 | MP0002736_abnormal_nociception_after | 3.42009453 |
| 9 | MP0002733_abnormal_thermal_nociception | 3.36924253 |
| 10 | MP0003566_abnormal_cell_adhesion | 3.15403686 |
| 11 | MP0005451_abnormal_body_composition | 3.14091750 |
| 12 | MP0006276_abnormal_autonomic_nervous | 3.09220148 |
| 13 | MP0001970_abnormal_pain_threshold | 3.02598969 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.99662334 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.77563997 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.65163119 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.60164513 |
| 18 | MP0001849_ear_inflammation | 2.57702888 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.50794101 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.50248568 |
| 21 | MP0002272_abnormal_nervous_system | 2.38260724 |
| 22 | MP0003329_amyloid_beta_deposits | 2.32805009 |
| 23 | MP0009840_abnormal_foam_cell | 2.25947517 |
| 24 | MP0005076_abnormal_cell_differentiation | 2.25417076 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.25310485 |
| 26 | MP0009046_muscle_twitch | 2.19438721 |
| 27 | MP0003880_abnormal_central_pattern | 2.16617271 |
| 28 | MP0002184_abnormal_innervation | 2.11728903 |
| 29 | MP0000751_myopathy | 2.11676322 |
| 30 | MP0005257_abnormal_intraocular_pressure | 2.08313835 |
| 31 | MP0002064_seizures | 2.01097018 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.98562718 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.88035846 |
| 34 | MP0002796_impaired_skin_barrier | 1.87176280 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.84879192 |
| 36 | MP0009745_abnormal_behavioral_response | 1.84210245 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.81331146 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.80931256 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.76800389 |
| 40 | MP0003091_abnormal_cell_migration | 1.76054914 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.74409385 |
| 42 | MP0002572_abnormal_emotion/affect_behav | 1.73235538 |
| 43 | MP0005409_darkened_coat_color | 1.70672968 |
| 44 | MP0000858_altered_metastatic_potential | 1.69158273 |
| 45 | MP0002060_abnormal_skin_morphology | 1.65450830 |
| 46 | MP0003279_aneurysm | 1.65007758 |
| 47 | MP0000955_abnormal_spinal_cord | 1.63602968 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.55461703 |
| 49 | MP0005501_abnormal_skin_physiology | 1.53873042 |
| 50 | MP0000733_abnormal_muscle_development | 1.53846978 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.53381223 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.52072545 |
| 53 | MP0009053_abnormal_anal_canal | 1.50578766 |
| 54 | MP0002751_abnormal_autonomic_nervous | 1.48401569 |
| 55 | MP0005423_abnormal_somatic_nervous | 1.47359160 |
| 56 | MP0000749_muscle_degeneration | 1.47017380 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.45159413 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.42886240 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.42063371 |
| 60 | MP0000467_abnormal_esophagus_morphology | 1.40977480 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.39098960 |
| 62 | MP0000920_abnormal_myelination | 1.35894903 |
| 63 | MP0008569_lethality_at_weaning | 1.34992520 |
| 64 | MP0003634_abnormal_glial_cell | 1.33815029 |
| 65 | MP0001348_abnormal_lacrimal_gland | 1.33632923 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.30986307 |
| 67 | MP0000747_muscle_weakness | 1.29737568 |
| 68 | MP0004947_skin_inflammation | 1.29451622 |
| 69 | MP0001958_emphysema | 1.26224453 |
| 70 | MP0009278_abnormal_bone_marrow | 1.25813117 |
| 71 | MP0004142_abnormal_muscle_tone | 1.25400866 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.24790539 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.24722522 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.23640034 |
| 75 | MP0005023_abnormal_wound_healing | 1.22472952 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.22265610 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.22263072 |
| 78 | MP0004510_myositis | 1.22055779 |
| 79 | MP0005623_abnormal_meninges_morphology | 1.22054509 |
| 80 | MP0000604_amyloidosis | 1.20726153 |
| 81 | MP0001486_abnormal_startle_reflex | 1.20156616 |
| 82 | MP0000778_abnormal_nervous_system | 1.18401202 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.17334241 |
| 84 | MP0004924_abnormal_behavior | 1.17334241 |
| 85 | MP0010030_abnormal_orbit_morphology | 1.16760656 |
| 86 | MP0003941_abnormal_skin_development | 1.15748814 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.14127809 |
| 88 | MP0002066_abnormal_motor_capabilities/c | 1.13777362 |
| 89 | MP0003303_peritoneal_inflammation | 1.12782474 |
| 90 | MP0000490_abnormal_crypts_of | 1.12011944 |
| 91 | MP0001299_abnormal_eye_distance/ | 1.11934611 |
| 92 | MP0000566_synostosis | 1.11606840 |
| 93 | MP0002229_neurodegeneration | 1.11181365 |
| 94 | MP0003633_abnormal_nervous_system | 1.09707578 |
| 95 | MP0002896_abnormal_bone_mineralization | 1.06840287 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 1.06421176 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.05401983 |
| 98 | MP0004036_abnormal_muscle_relaxation | 1.04244946 |
| 99 | MP0001216_abnormal_epidermal_layer | 1.03447170 |
| 100 | MP0000579_abnormal_nail_morphology | 1.03159299 |
| 101 | MP0005666_abnormal_adipose_tissue | 1.01875295 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 1.00058697 |
| 103 | MP0003045_fibrosis | 0.99741779 |
| 104 | MP0003879_abnormal_hair_cell | 0.99384074 |
| 105 | MP0002557_abnormal_social/conspecific_i | 0.97515426 |
| 106 | MP0003436_decreased_susceptibility_to | 0.96815500 |
| 107 | MP0001905_abnormal_dopamine_level | 0.96062608 |
| 108 | MP0009672_abnormal_birth_weight | 0.94560867 |
| 109 | MP0005621_abnormal_cell_physiology | 0.93788227 |
| 110 | MP0005375_adipose_tissue_phenotype | 0.93581719 |
| 111 | MP0003631_nervous_system_phenotype | 0.92760549 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.91844149 |
| 113 | MP0000759_abnormal_skeletal_muscle | 0.89995136 |
| 114 | MP0009931_abnormal_skin_appearance | 0.89907183 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.89023372 |
| 116 | MP0001915_intracranial_hemorrhage | 0.88694128 |
| 117 | MP0001730_embryonic_growth_arrest | 0.87804454 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.87691001 |
| 119 | MP0004742_abnormal_vestibular_system | 0.87425904 |
| 120 | MP0005410_abnormal_fertilization | 0.87037372 |
| 121 | MP0003075_altered_response_to | 0.86842176 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.85287057 |
| 123 | MP0003448_altered_tumor_morphology | 0.84902687 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.84854530 |
| 125 | MP0006138_congestive_heart_failure | 0.84736740 |
| 126 | MP0001270_distended_abdomen | 0.84729471 |
| 127 | MP0008260_abnormal_autophagy | 0.84621026 |
| 128 | MP0002254_reproductive_system_inflammat | 0.84206790 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.83777405 |
| 130 | MP0010307_abnormal_tumor_latency | 0.82681393 |
| 131 | MP0005083_abnormal_biliary_tract | 0.81876253 |
| 132 | MP0000762_abnormal_tongue_morphology | 0.81681413 |
| 133 | MP0004130_abnormal_muscle_cell | 0.81416216 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.81370199 |
| 135 | MP0001243_abnormal_dermal_layer | 0.80796863 |
| 136 | MP0001873_stomach_inflammation | 0.79545867 |
| 137 | MP0005275_abnormal_skin_tensile | 0.78268557 |
| 138 | MP0003828_pulmonary_edema | 0.77896095 |
| 139 | MP0003122_maternal_imprinting | 0.77283160 |
| 140 | MP0002080_prenatal_lethality | 0.76902585 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.76281799 |
| 142 | MP0002269_muscular_atrophy | 0.75350661 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.75308235 |
| 144 | MP0004808_abnormal_hematopoietic_stem | 0.73416792 |
| 145 | MP0002086_abnormal_extraembryonic_tissu | 0.73028285 |
| 146 | MP0004272_abnormal_basement_membrane | 0.72961524 |
| 147 | MP0005508_abnormal_skeleton_morphology | 0.72832513 |
| 148 | MP0000534_abnormal_ureter_morphology | 0.72099250 |
| 149 | MP0005645_abnormal_hypothalamus_physiol | 0.71098955 |
| 150 | MP0006082_CNS_inflammation | 0.70896753 |
| 151 | MP0000343_altered_response_to | 0.70199988 |
| 152 | MP0003632_abnormal_nervous_system | 0.70140965 |
| 153 | MP0009333_abnormal_splenocyte_physiolog | 0.69749319 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.69396653 |
| 155 | MP0010771_integument_phenotype | 0.69342571 |
| 156 | MP0005535_abnormal_body_temperature | 0.69227824 |
| 157 | MP0008874_decreased_physiological_sensi | 0.68894860 |
| 158 | MP0004084_abnormal_cardiac_muscle | 0.68611157 |
| 159 | MP0001542_abnormal_bone_strength | 0.68545860 |
| 160 | MP0001533_abnormal_skeleton_physiology | 0.68060122 |
| 161 | MP0004484_altered_response_of | 0.66868669 |
| 162 | MP0000477_abnormal_intestine_morphology | 0.66696963 |
| 163 | MP0001984_abnormal_olfaction | 0.66310199 |
| 164 | MP0002972_abnormal_cardiac_muscle | 0.65275858 |
| 165 | MP0005390_skeleton_phenotype | 0.65045563 |
| 166 | MP0002098_abnormal_vibrissa_morphology | 0.64758786 |
| 167 | MP0001614_abnormal_blood_vessel | 0.64711334 |
| 168 | MP0004085_abnormal_heartbeat | 0.64326464 |
| 169 | MP0004885_abnormal_endolymph | 0.64206947 |
| 170 | MP0000350_abnormal_cell_proliferation | 0.64050896 |
| 171 | MP0002396_abnormal_hematopoietic_system | 0.63994569 |
| 172 | MP0000003_abnormal_adipose_tissue | 0.61103071 |
| 173 | MP0001502_abnormal_circadian_rhythm | 0.59854141 |
| 174 | MP0001664_abnormal_digestion | 0.59580324 |
| 175 | MP0001756_abnormal_urination | 0.59131516 |
| 176 | MP0000750_abnormal_muscle_regeneration | 0.58848719 |
| 177 | MP0003690_abnormal_glial_cell | 0.58286783 |
| 178 | MP0002090_abnormal_vision | 0.56940627 |
| 179 | MP0002332_abnormal_exercise_endurance | 0.56241590 |
| 180 | MP0002106_abnormal_muscle_physiology | 0.56198600 |
| 181 | MP0005620_abnormal_muscle_contractility | 0.55897017 |
| 182 | MP0004233_abnormal_muscle_weight | 0.55550617 |
| 183 | MP0001963_abnormal_hearing_physiology | 0.55155133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.43547170 |
| 2 | Ulnar claw (HP:0001178) | 6.40742733 |
| 3 | Action tremor (HP:0002345) | 5.29994958 |
| 4 | Insidious onset (HP:0003587) | 4.73272674 |
| 5 | Termporal pattern (HP:0011008) | 4.73272674 |
| 6 | Pheochromocytoma (HP:0002666) | 4.09023476 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.06065641 |
| 8 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.03200780 |
| 9 | Protrusio acetabuli (HP:0003179) | 3.79958690 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.66906381 |
| 11 | Hypercortisolism (HP:0001578) | 3.54429405 |
| 12 | Ankle clonus (HP:0011448) | 3.44591608 |
| 13 | Myotonia (HP:0002486) | 3.43716570 |
| 14 | Foot dorsiflexor weakness (HP:0009027) | 3.34773939 |
| 15 | Focal seizures (HP:0007359) | 3.34091636 |
| 16 | Hammertoe (HP:0001765) | 3.29312010 |
| 17 | Atonic seizures (HP:0010819) | 3.23482599 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.19437329 |
| 19 | Hyperacusis (HP:0010780) | 3.19116006 |
| 20 | Focal motor seizures (HP:0011153) | 3.06520599 |
| 21 | Impaired pain sensation (HP:0007328) | 3.03979385 |
| 22 | Abnormality of pain sensation (HP:0010832) | 3.03979385 |
| 23 | Increased connective tissue (HP:0009025) | 3.02465592 |
| 24 | Visual hallucinations (HP:0002367) | 3.02069924 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.01746564 |
| 26 | Steppage gait (HP:0003376) | 2.97838898 |
| 27 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.97179008 |
| 28 | Abnormality of the foot musculature (HP:0001436) | 2.94299081 |
| 29 | Abnormality of the vocal cords (HP:0008777) | 2.90517907 |
| 30 | Hypoventilation (HP:0002791) | 2.89978181 |
| 31 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.89543670 |
| 32 | Onion bulb formation (HP:0003383) | 2.83473859 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 2.80120651 |
| 34 | Peripheral hypomyelination (HP:0007182) | 2.74242353 |
| 35 | Atrophic scars (HP:0001075) | 2.72257262 |
| 36 | Fragile skin (HP:0001030) | 2.72064625 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.70771456 |
| 38 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.69693936 |
| 39 | Failure to thrive in infancy (HP:0001531) | 2.69573204 |
| 40 | Postural tremor (HP:0002174) | 2.69210590 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.68479467 |
| 42 | Insomnia (HP:0100785) | 2.66681114 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 2.63472569 |
| 44 | Spinal rigidity (HP:0003306) | 2.62591217 |
| 45 | Long palpebral fissure (HP:0000637) | 2.61917088 |
| 46 | Hyporeflexia of lower limbs (HP:0002600) | 2.61806669 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.56053365 |
| 48 | Febrile seizures (HP:0002373) | 2.55240275 |
| 49 | Dysautonomia (HP:0002459) | 2.54467018 |
| 50 | Decreased motor nerve conduction velocity (HP:0003431) | 2.53123249 |
| 51 | Broad face (HP:0000283) | 2.47299894 |
| 52 | Rapidly progressive (HP:0003678) | 2.47274871 |
| 53 | Distal sensory impairment (HP:0002936) | 2.44849003 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.44274930 |
| 55 | Distal arthrogryposis (HP:0005684) | 2.43414628 |
| 56 | Reticulocytosis (HP:0001923) | 2.43058422 |
| 57 | Absence seizures (HP:0002121) | 2.43000866 |
| 58 | Cervical subluxation (HP:0003308) | 2.40675408 |
| 59 | Urinary urgency (HP:0000012) | 2.35656839 |
| 60 | Thin bony cortex (HP:0002753) | 2.35296140 |
| 61 | Disproportionate tall stature (HP:0001519) | 2.35186214 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.34663370 |
| 63 | Depression (HP:0000716) | 2.32789136 |
| 64 | Polycythemia (HP:0001901) | 2.31933168 |
| 65 | Epileptic encephalopathy (HP:0200134) | 2.31069798 |
| 66 | Generalized tonic-clonic seizures (HP:0002069) | 2.29351732 |
| 67 | Shallow orbits (HP:0000586) | 2.28555054 |
| 68 | Ulnar bowing (HP:0003031) | 2.28468303 |
| 69 | Blue sclerae (HP:0000592) | 2.27535970 |
| 70 | Arterial tortuosity (HP:0005116) | 2.23215368 |
| 71 | Trismus (HP:0000211) | 2.22889967 |
| 72 | Amblyopia (HP:0000646) | 2.22535671 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.22038606 |
| 74 | Dialeptic seizures (HP:0011146) | 2.21410348 |
| 75 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.21335023 |
| 76 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.19946552 |
| 77 | Natal tooth (HP:0000695) | 2.19570771 |
| 78 | Flat acetabular roof (HP:0003180) | 2.19036294 |
| 79 | Cerebral inclusion bodies (HP:0100314) | 2.18456274 |
| 80 | Spastic gait (HP:0002064) | 2.17900603 |
| 81 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16780911 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.14878537 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14878537 |
| 84 | Short nail (HP:0001799) | 2.14005552 |
| 85 | Sparse lateral eyebrow (HP:0005338) | 2.13768618 |
| 86 | Ankle contracture (HP:0006466) | 2.12848220 |
| 87 | Achilles tendon contracture (HP:0001771) | 2.12489935 |
| 88 | Delusions (HP:0000746) | 2.11564274 |
| 89 | Vascular tortuosity (HP:0004948) | 2.10833441 |
| 90 | Hyperparathyroidism (HP:0000843) | 2.09126634 |
| 91 | Agitation (HP:0000713) | 2.08824877 |
| 92 | Mucopolysacchariduria (HP:0008155) | 2.08764156 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08764156 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08327905 |
| 95 | Limb dystonia (HP:0002451) | 2.08193053 |
| 96 | Obstructive sleep apnea (HP:0002870) | 2.08060754 |
| 97 | Truncal ataxia (HP:0002078) | 2.07590643 |
| 98 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.06206505 |
| 99 | Hypoplasia of the brainstem (HP:0002365) | 2.06206505 |
| 100 | Muscle stiffness (HP:0003552) | 2.04451289 |
| 101 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03643875 |
| 102 | Selective tooth agenesis (HP:0001592) | 2.01783599 |
| 103 | Autoamputation (HP:0001218) | 2.00820879 |
| 104 | Increased CSF protein (HP:0002922) | 2.00809191 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99360879 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99360879 |
| 107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99360879 |
| 108 | Type 1 muscle fiber predominance (HP:0003803) | 1.99017281 |
| 109 | Anxiety (HP:0000739) | 1.98832722 |
| 110 | Hand muscle atrophy (HP:0009130) | 1.97995776 |
| 111 | Retinal dysplasia (HP:0007973) | 1.97162344 |
| 112 | Genu recurvatum (HP:0002816) | 1.97152794 |
| 113 | Akinesia (HP:0002304) | 1.96693298 |
| 114 | Abnormal eating behavior (HP:0100738) | 1.96664777 |
| 115 | Lower limb muscle weakness (HP:0007340) | 1.96409538 |
| 116 | Mitral regurgitation (HP:0001653) | 1.96138243 |
| 117 | Myopathic facies (HP:0002058) | 1.95072487 |
| 118 | Cholelithiasis (HP:0001081) | 1.94768745 |
| 119 | Advanced eruption of teeth (HP:0006288) | 1.94166937 |
| 120 | Bradycardia (HP:0001662) | 1.92636547 |
| 121 | Bladder diverticulum (HP:0000015) | 1.92431312 |
| 122 | Diaphragmatic weakness (HP:0009113) | 1.91095857 |
| 123 | Abnormality of the lower motor neuron (HP:0002366) | 1.90776136 |
| 124 | Lower limb amyotrophy (HP:0007210) | 1.90270651 |
| 125 | Dysmetria (HP:0001310) | 1.90007534 |
| 126 | Cerebral hemorrhage (HP:0001342) | 1.89698905 |
| 127 | Wormian bones (HP:0002645) | 1.89039209 |
| 128 | Upper limb amyotrophy (HP:0009129) | 1.89006773 |
| 129 | Distal upper limb amyotrophy (HP:0007149) | 1.89006773 |
| 130 | Difficulty climbing stairs (HP:0003551) | 1.86439372 |
| 131 | Generalized amyotrophy (HP:0003700) | 1.86126607 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85647116 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85647116 |
| 134 | Slow progression (HP:0003677) | 1.85188133 |
| 135 | Megalencephaly (HP:0001355) | 1.85029309 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.84428097 |
| 137 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.84356410 |
| 138 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.83149711 |
| 139 | Neuronal loss in central nervous system (HP:0002529) | 1.83072637 |
| 140 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82892745 |
| 141 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82892745 |
| 142 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82892745 |
| 143 | Difficulty running (HP:0009046) | 1.82687127 |
| 144 | Scanning speech (HP:0002168) | 1.80700623 |
| 145 | Impaired proprioception (HP:0010831) | 1.80632597 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.80221083 |
| 147 | Back pain (HP:0003418) | 1.79871939 |
| 148 | Elbow flexion contracture (HP:0002987) | 1.78344724 |
| 149 | Dilatation of the ascending aorta (HP:0005111) | 1.77693304 |
| 150 | Abnormality of oral frenula (HP:0000190) | 1.77329174 |
| 151 | Ankyloglossia (HP:0010296) | 1.77023256 |
| 152 | Mutism (HP:0002300) | 1.76499035 |
| 153 | Abnormality of the thoracic spine (HP:0100711) | 1.76467053 |
| 154 | Axonal loss (HP:0003447) | 1.75723300 |
| 155 | Menstrual irregularities (HP:0000858) | 1.75010026 |
| 156 | Premature rupture of membranes (HP:0001788) | 1.74741340 |
| 157 | Abnormal gallbladder physiology (HP:0012438) | 1.74555685 |
| 158 | Cholecystitis (HP:0001082) | 1.74555685 |
| 159 | Biconcave vertebral bodies (HP:0004586) | 1.74507572 |
| 160 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.73973006 |
| 161 | Torticollis (HP:0000473) | 1.71939318 |
| 162 | Polygenic inheritance (HP:0010982) | 1.71913916 |
| 163 | Congenital glaucoma (HP:0001087) | 1.71718568 |
| 164 | Growth hormone excess (HP:0000845) | 1.71492014 |
| 165 | Stridor (HP:0010307) | 1.70131352 |
| 166 | Peripheral demyelination (HP:0011096) | 1.69261801 |
| 167 | Poor suck (HP:0002033) | 1.68944007 |
| 168 | Syringomyelia (HP:0003396) | 1.68875790 |
| 169 | Spinal cord lesions (HP:0100561) | 1.68875790 |
| 170 | Adrenal overactivity (HP:0002717) | 1.68758097 |
| 171 | Clonus (HP:0002169) | 1.68327125 |
| 172 | Interstitial pulmonary disease (HP:0006530) | 1.67414750 |
| 173 | Spinal cord compression (HP:0002176) | 1.67220650 |
| 174 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.65807899 |
| 175 | Bulbar palsy (HP:0001283) | 1.64796754 |
| 176 | J-shaped sella turcica (HP:0002680) | 1.64754477 |
| 177 | Abnormality of nail color (HP:0100643) | 1.63662175 |
| 178 | Aortic dissection (HP:0002647) | 1.62377121 |
| 179 | Neonatal death (HP:0003811) | 1.61090306 |
| 180 | Pterygium (HP:0001059) | 1.60349788 |
| 181 | Hypertensive crisis (HP:0100735) | 1.59721087 |
| 182 | Aneurysm (HP:0002617) | 1.59363361 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.59160602 |
| 184 | Nonimmune hydrops fetalis (HP:0001790) | 1.58866541 |
| 185 | Mitral valve prolapse (HP:0001634) | 1.58771834 |
| 186 | Abnormal ossification of hand bones (HP:0005921) | 1.58511700 |
| 187 | Abnormal gallbladder morphology (HP:0012437) | 1.57529925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 3.69476000 |
| 2 | MAP3K9 | 3.33173444 |
| 3 | KSR2 | 3.31536875 |
| 4 | NTRK3 | 3.24496211 |
| 5 | PRPF4B | 3.22696827 |
| 6 | IRAK3 | 3.17820159 |
| 7 | LIMK1 | 3.17121945 |
| 8 | MINK1 | 2.96129187 |
| 9 | SMG1 | 2.87770125 |
| 10 | LMTK2 | 2.67029215 |
| 11 | GRK5 | 2.66295431 |
| 12 | EEF2K | 2.64673941 |
| 13 | SIK1 | 2.55834246 |
| 14 | NME2 | 2.42460535 |
| 15 | TTN | 2.34056890 |
| 16 | MAP3K2 | 2.32805785 |
| 17 | PAK6 | 2.28993544 |
| 18 | LATS2 | 2.27890338 |
| 19 | ERN1 | 2.16011093 |
| 20 | EPHA2 | 2.13980576 |
| 21 | ARAF | 2.13228931 |
| 22 | MAP3K3 | 1.99101617 |
| 23 | ICK | 1.92434199 |
| 24 | MAP3K12 | 1.87445920 |
| 25 | RET | 1.80414805 |
| 26 | PAK4 | 1.79803329 |
| 27 | PHKG2 | 1.72541834 |
| 28 | PHKG1 | 1.72541834 |
| 29 | TAOK2 | 1.69672711 |
| 30 | TESK1 | 1.66944930 |
| 31 | RIPK4 | 1.66809089 |
| 32 | PKN2 | 1.66738077 |
| 33 | FER | 1.58812299 |
| 34 | MAPKAPK3 | 1.58267949 |
| 35 | MAP2K3 | 1.55660273 |
| 36 | MAP3K4 | 1.55512249 |
| 37 | MST1R | 1.49866275 |
| 38 | STK39 | 1.49692697 |
| 39 | MAP2K4 | 1.47878108 |
| 40 | MARK1 | 1.46993679 |
| 41 | MAP3K10 | 1.42989643 |
| 42 | FGFR4 | 1.42747506 |
| 43 | DAPK2 | 1.39393076 |
| 44 | CDK12 | 1.35222517 |
| 45 | WNK1 | 1.31141478 |
| 46 | MAP2K1 | 1.24742640 |
| 47 | PRKD3 | 1.24712427 |
| 48 | CAMKK2 | 1.22873291 |
| 49 | RIPK1 | 1.22431048 |
| 50 | STK24 | 1.21098256 |
| 51 | PTK6 | 1.17664523 |
| 52 | CDK5 | 1.17398873 |
| 53 | MAP3K1 | 1.17367627 |
| 54 | UHMK1 | 1.13515229 |
| 55 | PTK2B | 1.12425334 |
| 56 | TRIB3 | 1.11493777 |
| 57 | PAK3 | 1.11353112 |
| 58 | WNK4 | 1.10654650 |
| 59 | CDK14 | 1.10055818 |
| 60 | EPHB1 | 1.09485993 |
| 61 | MATK | 1.08068080 |
| 62 | BMX | 1.02721138 |
| 63 | CAMKK1 | 1.00791171 |
| 64 | MTOR | 0.97477614 |
| 65 | EPHB2 | 0.96538266 |
| 66 | MET | 0.95898180 |
| 67 | MAPK13 | 0.93888307 |
| 68 | EPHA3 | 0.93301955 |
| 69 | JAK3 | 0.93045789 |
| 70 | MAPKAPK5 | 0.92016158 |
| 71 | MAP3K11 | 0.91453148 |
| 72 | STK38 | 0.90427175 |
| 73 | BRAF | 0.89858784 |
| 74 | PRKD2 | 0.89508649 |
| 75 | MAP2K7 | 0.88513815 |
| 76 | PINK1 | 0.88177875 |
| 77 | TESK2 | 0.88131355 |
| 78 | MAP3K8 | 0.83795910 |
| 79 | CDK15 | 0.80144699 |
| 80 | CDK18 | 0.79895620 |
| 81 | RPS6KL1 | 0.79492650 |
| 82 | RPS6KC1 | 0.79492650 |
| 83 | ROCK2 | 0.78238711 |
| 84 | IRAK2 | 0.77588381 |
| 85 | LRRK2 | 0.77160798 |
| 86 | MAP3K6 | 0.75088391 |
| 87 | RPS6KA2 | 0.74864981 |
| 88 | TBK1 | 0.74234327 |
| 89 | MAP2K2 | 0.73570030 |
| 90 | DAPK3 | 0.71931710 |
| 91 | CDK11A | 0.71690898 |
| 92 | CDK19 | 0.71067172 |
| 93 | CAMK1D | 0.70233531 |
| 94 | PTK2 | 0.69979024 |
| 95 | DDR2 | 0.66987187 |
| 96 | CASK | 0.66672824 |
| 97 | RPS6KB2 | 0.66612405 |
| 98 | PRKCG | 0.65225997 |
| 99 | PLK2 | 0.65121841 |
| 100 | TYRO3 | 0.64484416 |
| 101 | SCYL2 | 0.63955725 |
| 102 | ADRBK1 | 0.62990675 |
| 103 | PRKCE | 0.61913944 |
| 104 | CAMK2G | 0.60907122 |
| 105 | ZAP70 | 0.60134018 |
| 106 | CAMK2A | 0.59348371 |
| 107 | PDPK1 | 0.58743478 |
| 108 | SGK223 | 0.58586329 |
| 109 | SGK494 | 0.58586329 |
| 110 | CAMK2D | 0.58505170 |
| 111 | CDC42BPA | 0.58452868 |
| 112 | IRAK4 | 0.58411180 |
| 113 | PIM2 | 0.57331275 |
| 114 | NEK1 | 0.56244227 |
| 115 | PDGFRA | 0.55354810 |
| 116 | MAP3K13 | 0.55207318 |
| 117 | PAK2 | 0.54079927 |
| 118 | PNCK | 0.53910901 |
| 119 | PRKG2 | 0.53229077 |
| 120 | CSNK1G2 | 0.52795340 |
| 121 | TAOK1 | 0.52169978 |
| 122 | EIF2AK1 | 0.51137319 |
| 123 | MYLK | 0.50723918 |
| 124 | RPS6KA6 | 0.50596002 |
| 125 | DAPK1 | 0.49707312 |
| 126 | NTRK2 | 0.49232047 |
| 127 | MOS | 0.48261878 |
| 128 | CDK7 | 0.46510127 |
| 129 | SIK3 | 0.46138144 |
| 130 | TNK2 | 0.45216449 |
| 131 | ABL2 | 0.45154679 |
| 132 | TYK2 | 0.43751898 |
| 133 | KSR1 | 0.43533097 |
| 134 | PRKCH | 0.43485797 |
| 135 | MARK2 | 0.42914672 |
| 136 | MAP3K14 | 0.42867634 |
| 137 | TRPM7 | 0.42381608 |
| 138 | MAPK11 | 0.42285745 |
| 139 | ROCK1 | 0.41567542 |
| 140 | ADRBK2 | 0.41347161 |
| 141 | GRK7 | 0.39698358 |
| 142 | OXSR1 | 0.39530112 |
| 143 | ILK | 0.37799177 |
| 144 | CSNK1G3 | 0.37510375 |
| 145 | AKT2 | 0.37487022 |
| 146 | CAMK1G | 0.37232625 |
| 147 | PDK4 | 0.36711033 |
| 148 | PDK3 | 0.36711033 |
| 149 | CAMK2B | 0.35960165 |
| 150 | PDK1 | 0.35188956 |
| 151 | CLK1 | 0.35181942 |
| 152 | ERBB4 | 0.34120698 |
| 153 | TGFBR2 | 0.32551779 |
| 154 | PRKCI | 0.31347542 |
| 155 | MAPKAPK2 | 0.30849828 |
| 156 | PDGFRB | 0.30608756 |
| 157 | PAK1 | 0.30220532 |
| 158 | CDK9 | 0.30202999 |
| 159 | MAPK12 | 0.30035528 |
| 160 | CCNB1 | 0.29360476 |
| 161 | GRK6 | 0.29310086 |
| 162 | AURKA | 0.27476565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.33560201 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.21283725 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.83469124 |
| 4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.72669548 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43559374 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.10661266 |
| 7 | Bladder cancer_Homo sapiens_hsa05219 | 1.97842059 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96328190 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.83235943 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80678778 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79362891 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.75453680 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.73189157 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71802098 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61714995 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59879229 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58785022 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.58404731 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56357549 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.55771320 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54466797 |
| 22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54419958 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52958437 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52833225 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51467802 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.50955149 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50923065 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49285674 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47940483 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.47733226 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47537102 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47335214 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.46833477 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.45823799 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.43280798 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42969257 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40808020 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39999849 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.37757504 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37620464 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.37098964 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.35004449 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34634273 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34092748 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.31387686 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29414807 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.28914488 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25804933 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.25642358 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.23553983 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21703535 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20149027 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.20129242 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19960794 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19394420 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 1.19363841 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.18795394 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.18565988 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18210796 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 1.18015821 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.13734615 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 1.10969502 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10457920 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09560341 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05869858 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04746238 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03815120 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02430606 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 1.01822070 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01629203 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00353104 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00219063 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.99917499 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97443600 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.96751259 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95257530 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94627734 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.92934425 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.92020870 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91477790 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90691588 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90510565 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90159000 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.89209046 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.88581382 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88263946 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87515903 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87112181 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87082495 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86436377 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86395604 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84998922 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84982952 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84363369 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82357103 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82180872 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81358943 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80678132 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80637368 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79861854 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78226635 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77875117 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77333929 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76082966 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75697995 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75155661 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74980449 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74896437 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74099572 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74063990 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.73319936 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73167318 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73139485 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72934853 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.71217578 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70718918 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70071044 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69139016 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69130159 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69129028 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68979762 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.68387964 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.67917935 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67688074 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.67052167 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64935668 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63586053 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63505260 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63319700 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.62536621 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.61285757 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60671334 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60553243 |
| 134 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60498881 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58618102 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58583033 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57209326 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57071710 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55850029 |
| 140 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54009030 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53909478 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53496708 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53048155 |
| 144 | Influenza A_Homo sapiens_hsa05164 | 0.52171259 |
| 145 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51190303 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50721531 |
| 147 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50445656 |
| 148 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48490336 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.48356237 |
| 150 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48352426 |
| 151 | Pertussis_Homo sapiens_hsa05133 | 0.47740650 |
| 152 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46841924 |
| 153 | Lysine degradation_Homo sapiens_hsa00310 | 0.46659683 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46618216 |
| 155 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46578544 |
| 156 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46354549 |
| 157 | Mineral absorption_Homo sapiens_hsa04978 | 0.45951766 |
| 158 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44588273 |
| 159 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44199861 |
| 160 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44135868 |
| 161 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43831046 |

